Adenosine in the airways: implications and applications.

The review approach synthesizes findings from animal and human studies. It analyzes bronchoalveolar lavage and breath condensate data. The authors examine adenosine's effects on mast cells and other immune cells. They compare adenosine levels in asthmatics versus healthy controls. The study reviews bronchial challenge tests using adenosine. It investigates receptor subtype distribution in airway cells. The analysis includes adenosine's role in modulating inflammation. The paper evaluates adenosine receptor modulation as a therapeutic strategy.

Adenosine levels are elevated in asthmatic airway secretions. Inhaled adenosine causes bronchoconstriction in asthmatics but not in healthy individuals. This effect is linked to mast cell release of inflammatory mediators. Adenosine also modulates neutrophils, eosinophils, and macrophages. The A2B receptor subtype appears central to these effects. Adenosine activates protective mechanisms against lung injury. Bronchial adenosine challenge reflects airway inflammation levels. The study shows adenosine's dual pro- and anti-inflammatory roles.

The authors propose that adenosine's effects are receptor subtype-dependent. They suggest that A2B receptors mediate pro-inflammatory responses. Adenosine's bronchoconstrictive effect is likely mast cell-mediated. The paper concludes that adenosine has protective roles in lung injury. The authors state that adenosine receptor modulation is a novel therapeutic approach. They suggest that adenosine challenge tests are clinically useful in asthma. The study implies that adenosine's effects depend on receptor distribution patterns. The authors propose that adenosine's dual roles explain its complex effects in asthma.